Table 2 –
Program | Delivery years | 1980–2010 |
2000–2010 |
||||||
---|---|---|---|---|---|---|---|---|---|
Total prevalence per 10 000 | 95% Confidence interval |
Quartilea | Total prevalence per 10 000 | 95% Confidence interval |
Quartilea | ||||
Lower | Upper | Lower | Upper | ||||||
Argentina | 2009–2010 | 2.14 | 1.11 | 4.83 | Q1 | 2.14 | 1.11 | 4.83 | Q1 |
Australia | 1980–2010 | 33.68 | 31.58 | 35.34 | Q4 | 36.21 | 34.26 | 38.32 | Q4 |
Canada (National) | 2005–2010 | 24.45 | 23.57 | 25.31 | Q3 | 24.45 | 23.57 | 25.31 | Q3 |
Alberta, Canada | 1980–2010 | 21.13 | 19.77 | 22.31 | Q3 | 21.51 | 19.84 | 22.94 | Q2 |
Chile-Maule | 2002–2010 | 8.26 | 6.62 | 9.85 | Q1 | 8.26 | 6.62 | 9.85 | Q1 |
Colombia | 2001–2010 | 4.70 | 4.24 | 9.17 | Q1 | 4.70 | 4.24 | 9.17 | Q1 |
Costa Rica | 1987–2010 | 4.77 | 4.24 | 5.42 | Q1 | 6.17 | 5.62 | 6.74 | Q1 |
Czech Republic | 1980–2010 | 25.64 | 24.31 | 27.72 | Q3 | 31.86 | 30.29 | 32.70 | Q4 |
Finland | 1993–2010 | 15.54 | 14.64 | 16.37 | Q2 | 15.97 | 14.74 | 17.11 | Q2 |
France | 1980–2010 | 10.60 | 9.56 | 11.54 | Q1 | 12.55 | 11.67 | 13.49 | Q1 |
Germany | 1987–2010 | 18.21 | 16.47 | 20.61 | Q2 | 19.32 | 17.09 | 21.65 | Q2 |
Hungary | 1980–2010 | 22.30 | 21.17 | 23.92 | Q3 | 25.78 | 23.28 | 28.35 | Q3 |
Iran | 2005–2010 | 13.69 | 8.70 | 18.41 | Q2 | 13.69 | 8.70 | 18.41 | Q2 |
Lombardia, Italy | 1999–2010 | 37.38 | 33.42 | 40.92 | Q4 | 38.11 | 34.17 | 41.70 | Q4 |
Tuscany, Italy | 1992–2010 | 19.22 | 17.15 | 21.16 | Q2 | 20.17 | 18.07 | 22.34 | Q2 |
Malta | 1993–2010 | 29.64 | 22.46 | 38.88 | Q4 | 36.45 | 26.22 | 47.28 | Q4 |
Mexico | 1980–2010 | 3.17 | 2.67 | 3.40 | Q1 | 2.75 | 2.04 | 3.53 | Q1 |
New Zealand | 1980–1993 | 19.61 | 16.56 | 22.21 | Q2 | 27.02 | 24.65 | 29.70 | Q3 |
1996–2010 | |||||||||
Northern Netherlands | 1981–2010 | 15.06 | 12.80 | 17.05 | Q2 | 20.04 | 17.39 | 22.98 | Q2 |
Slovak Republic | 1995–2010 | 21.98 | 20.30 | 23.81 | Q3 | 21.35 | 19.09 | 23.93 | Q2 |
Spain | 1980–2010 | 14.75 | 14.12 | 16.34 | Q2 | 12.11 | 11.47 | 12.73 | Q1 |
Sweden | 1980–2010 | 20.01 | 18.52 | 21.48 | Q3 | 24.97 | 23.39 | 26.26 | Q3 |
Arkansas, USA | 1993–2010 | 39.11 | 36.67 | 41.43 | Q4 | 40.13 | 36.67 | 43.50 | Q4 |
Atlanta, GA, USA | 1980–2010 | 31.28 | 29.66 | 32.70 | Q4 | 30.21 | 27.99 | 32.61 | Q3 |
Texas, USA | 1996–2010 | 28.14 | 26.36 | 29.01 | Q3 | 28.57 | 27.32 | 29.75 | Q3 |
Utah, USA | 1999–2010 | 30.59 | 28.03 | 32.84 | Q4 | 31.05 | 28.52 | 33.34 | Q3 |
Wales | 1998–2010 | 31.65 | 30.57 | 32.80 | Q4 | 32.15 | 31.25 | 33.13 | Q4 |
Total | – | 20.91 | 19.19 | 22.63 | – | 23.78 | 22.06 | 25.50 | – |
Q1 corresponds to the lowest quartile of total prevalence and Q4 corresponds to the highest quartile.